Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA).
The global decline in prevalence of lymphatic filariasis has been one of the major successes of the WHO's NTD programme. The recommended strategy of intensive, community-wide mass drug administration, aims to break localised transmission by either reducing the prevalence of microfilaria positiv...
Saved in:
Main Authors: | Benjamin S Collyer (Author), Michael A Irvine (Author), T Deidre Hollingsworth (Author), Mark Bradley (Author), Roy M Anderson (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fifteen years of programme implementation for the elimination of Lymphatic Filariasis in Ghana: Impact of MDA on immunoparasitological indicators.
by: Nana-Kwadwo Biritwum, et al.
Published: (2017) -
Review of MDA registers for Lymphatic Filariasis: Findings, and potential uses in addressing the endgame elimination challenges.
by: Dziedzom K de Souza, et al.
Published: (2020) -
Elimination of lymphatic filariasis in the Gambia.
by: Maria P Rebollo, et al.
Published: (2015) -
Costs of Transmission Assessment Surveys to Provide Evidence for the Elimination of Lymphatic Filariasis.
by: Molly A Brady, et al.
Published: (2017) -
Population migration: implications for lymphatic filariasis elimination programmes.
by: K D Ramaiah
Published: (2013)